Wall Street Analysts See a 26.05% Upside in Corcept (CORT): Can the Stock Really Move This High?
Portfolio Pulse from
Wall Street analysts have set a consensus price target for Corcept Therapeutics (CORT) that suggests a 26.1% upside potential. Despite skepticism about the effectiveness of price targets, positive earnings estimate revisions could indicate a near-term upside for the stock.
December 06, 2024 | 4:00 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Corcept Therapeutics (CORT) has a consensus price target indicating a 26.1% upside. Positive earnings estimate revisions suggest potential near-term gains.
The consensus price target for CORT suggests a significant upside. While price targets alone may not be reliable, the upward trend in earnings estimate revisions provides a strong indicator of potential stock price increase in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100